메뉴 건너뛰기




Volumn 20, Issue 2, 2017, Pages 261-265

Toward a Hedonic Value Framework in Health Care

Author keywords

hedonic pricing; insurance; value; value framework

Indexed keywords

ARTICLE; CONTINGENT VALUATION; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; GOVERNMENT; HEALTH CARE; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE PLANNING; HEALTH INSURANCE; HUMAN; MARKET; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RESOURCE ALLOCATION; BIOMEDICAL TECHNOLOGY ASSESSMENT; COMMERCIAL PHENOMENA; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMIC ASPECT; HEALTH CARE DELIVERY; INSURANCE; PROCEDURES; PURCHASING; THEORETICAL MODEL; UNITED STATES;

EID: 85013654118     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2016.11.022     Document Type: Article
Times cited : (10)

References (33)
  • 1
    • 0001791734 scopus 로고
    • Hedonic prices and implicit markets: product differentiation in pure competition
    • [1] Rosen, S., Hedonic prices and implicit markets: product differentiation in pure competition. J Polit Econ 82 (1974), 34–55.
    • (1974) J Polit Econ , vol.82 , pp. 34-55
    • Rosen, S.1
  • 2
    • 0004023290 scopus 로고    scopus 로고
    • Stated Choice Methods: Analytics and Applications
    • Cambridge University Press New York, NY
    • [2] Louviere, J., Hensher, D., Swait, J., Stated Choice Methods: Analytics and Applications. 2000, Cambridge University Press, New York, NY.
    • (2000)
    • Louviere, J.1    Hensher, D.2    Swait, J.3
  • 3
    • 3042576511 scopus 로고    scopus 로고
    • Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics
    • [3] Bridges, J.F., Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. Appl Health Econ Health Policy 2 (2003), 213–224.
    • (2003) Appl Health Econ Health Policy , vol.2 , pp. 213-224
    • Bridges, J.F.1
  • 4
    • 85009075672 scopus 로고    scopus 로고
    • The insurance value of medical innovation
    • National Bureau of Economic Research Cambridge, MA
    • [4] Lakdawalla, D., Malani, A., Reif, J., The insurance value of medical innovation. NBER Working Paper No. 21015, 2015, National Bureau of Economic Research, Cambridge, MA.
    • (2015) NBER Working Paper No. 21015
    • Lakdawalla, D.1    Malani, A.2    Reif, J.3
  • 5
    • 84892588228 scopus 로고    scopus 로고
    • Budget impact analysis—principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force
    • [5] Sullivan, S.D., Mauskopf, J.A., Augustovski, F., et al. Budget impact analysis—principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health 17 (2014), 5–14.
    • (2014) Value Health , vol.17 , pp. 5-14
    • Sullivan, S.D.1    Mauskopf, J.A.2    Augustovski, F.3
  • 6
    • 0002338136 scopus 로고
    • Commercial use of conjoint analysis: a survey
    • [6] Cattin, P., Wittink, D., Commercial use of conjoint analysis: a survey. J Mark 46 (1982), 44–53.
    • (1982) J Mark , vol.46 , pp. 44-53
    • Cattin, P.1    Wittink, D.2
  • 7
    • 79960121694 scopus 로고    scopus 로고
    • Discrete choice experiments are not conjoint analysis
    • [7] Louviere, J.J., Flynn, T.N., Carson, R.T., Discrete choice experiments are not conjoint analysis. J Choice Model 3 (2010), 57–72.
    • (2010) J Choice Model , vol.3 , pp. 57-72
    • Louviere, J.J.1    Flynn, T.N.2    Carson, R.T.3
  • 8
    • 0000142503 scopus 로고
    • The choice theory approach to market research
    • [8] McFadden, D., The choice theory approach to market research. Mark Sci 5 (1986), 275–297.
    • (1986) Mark Sci , vol.5 , pp. 275-297
    • McFadden, D.1
  • 9
    • 0034365737 scopus 로고    scopus 로고
    • Mixed MNL models for discrete response
    • [9] McFadden, D., Train, K., Mixed MNL models for discrete response. J Appl Econ 15 (2000), 447–470.
    • (2000) J Appl Econ , vol.15 , pp. 447-470
    • McFadden, D.1    Train, K.2
  • 10
    • 0030796960 scopus 로고    scopus 로고
    • Using conjoint analysis to assess women's preferences for miscarriage management
    • [10] Ryan, M., Hughes, M., Using conjoint analysis to assess women's preferences for miscarriage management. Health Econ 6 (1997), 261–273.
    • (1997) Health Econ , vol.6 , pp. 261-273
    • Ryan, M.1    Hughes, M.2
  • 11
    • 0032945923 scopus 로고    scopus 로고
    • Using conjoint analysis to go beyond health outcomes and take account of patient preferences: an application to in vitro fertilisation
    • [11] Ryan, M., Using conjoint analysis to go beyond health outcomes and take account of patient preferences: an application to in vitro fertilisation. Soc Sci Med 8 (1999), 535–546.
    • (1999) Soc Sci Med , vol.8 , pp. 535-546
    • Ryan, M.1
  • 12
    • 84872666170 scopus 로고    scopus 로고
    • A discrete-choice experiment of United Kingdom patients’ willingness to risk adverse events for improved function and pain control in osteoarthritis
    • [12] Hauber, A.B., Arden, N.K., Mohamed, A.F., et al. A discrete-choice experiment of United Kingdom patients’ willingness to risk adverse events for improved function and pain control in osteoarthritis. Osteoarthritis Cartilage 21 (2013), 289–297.
    • (2013) Osteoarthritis Cartilage , vol.21 , pp. 289-297
    • Hauber, A.B.1    Arden, N.K.2    Mohamed, A.F.3
  • 13
    • 84966698437 scopus 로고    scopus 로고
    • Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR Conjoint Analysis Good Research Practices Task Force
    • [13] Hauber, A.B., González, J.M., Groothuis-Oudshoorn, C.G.M., et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR Conjoint Analysis Good Research Practices Task Force. Value Health 19 (2016), 300–315.
    • (2016) Value Health , vol.19 , pp. 300-315
    • Hauber, A.B.1    González, J.M.2    Groothuis-Oudshoorn, C.G.M.3
  • 14
    • 84872731697 scopus 로고    scopus 로고
    • Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force
    • [14] Johnson, F.R., Lancsar, E., Marshall, D., et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health 16 (2013), 3–13.
    • (2013) Value Health , vol.16 , pp. 3-13
    • Johnson, F.R.1    Lancsar, E.2    Marshall, D.3
  • 15
    • 84903307466 scopus 로고    scopus 로고
    • Discrete choice experiment to estimate breast cancer patients’ preferences and willingness to pay for prophylactic granulocyte colony-stimulating factors
    • [15] Johnson, P., Bancroft, T., Barron, R., et al. Discrete choice experiment to estimate breast cancer patients’ preferences and willingness to pay for prophylactic granulocyte colony-stimulating factors. Value Health 17 (2014), 380–389.
    • (2014) Value Health , vol.17 , pp. 380-389
    • Johnson, P.1    Bancroft, T.2    Barron, R.3
  • 16
    • 33746298854 scopus 로고    scopus 로고
    • Using discrete choice experiments within a cost-benefit analysis framework
    • [16] McIntosh, E., Using discrete choice experiments within a cost-benefit analysis framework. Pharmacoeconomics 24 (2006), 855–868.
    • (2006) Pharmacoeconomics , vol.24 , pp. 855-868
    • McIntosh, E.1
  • 17
    • 1442276463 scopus 로고    scopus 로고
    • A comparison of stated preference methods for estimating monetary values
    • [17] Ryan, M., A comparison of stated preference methods for estimating monetary values. Health Econ 13 (2004), 291–296.
    • (2004) Health Econ , vol.13 , pp. 291-296
    • Ryan, M.1
  • 18
    • 84855545457 scopus 로고    scopus 로고
    • Discrete choice experiments in health economics: a review of the literature
    • [18] De Bekker-Grob, E.W., Ryan, M., Gerard, K., Discrete choice experiments in health economics: a review of the literature. Health Econ 21 (2012), 145–172.
    • (2012) Health Econ , vol.21 , pp. 145-172
    • De Bekker-Grob, E.W.1    Ryan, M.2    Gerard, K.3
  • 19
    • 84928733114 scopus 로고    scopus 로고
    • Consistency between stated and revealed preferences: a discrete choice experiment and a behavioural experiment on vaccination behaviour compared
    • [19] Lambooji, M.S., Harmsen, I.A., Veldwijk, J., et al. Consistency between stated and revealed preferences: a discrete choice experiment and a behavioural experiment on vaccination behaviour compared. BMC Med Res Methodol, 15, 2015, 19.
    • (2015) BMC Med Res Methodol , vol.15 , pp. 19
    • Lambooji, M.S.1    Harmsen, I.A.2    Veldwijk, J.3
  • 20
    • 10344220579 scopus 로고    scopus 로고
    • Validation of stated preferences for public goods: a comparison of contingent valuation survey response and voting behaviour
    • [20] Schläpfer, F., Roschewitz, A., Hanley, N., Validation of stated preferences for public goods: a comparison of contingent valuation survey response and voting behaviour. Ecol Econ 51 (2004), 1–16.
    • (2004) Ecol Econ , vol.51 , pp. 1-16
    • Schläpfer, F.1    Roschewitz, A.2    Hanley, N.3
  • 21
    • 84995877260 scopus 로고    scopus 로고
    • Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses in health and medicine: the Second Panel on Cost-Effectiveness in Health and Medicine
    • [21] Sanders, G.D., Neumann, P.J., Basu, A., et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses in health and medicine: the Second Panel on Cost-Effectiveness in Health and Medicine. JAMA 316 (2016), 1093–1103.
    • (2016) JAMA , vol.316 , pp. 1093-1103
    • Sanders, G.D.1    Neumann, P.J.2    Basu, A.3
  • 22
    • 0030919507 scopus 로고    scopus 로고
    • Economic foundations of cost-effectiveness analysis
    • [22] Garber, A.M., Phelps, C.E., Economic foundations of cost-effectiveness analysis. J Health Econ 16 (1997), 1–31.
    • (1997) J Health Econ , vol.16 , pp. 1-31
    • Garber, A.M.1    Phelps, C.E.2
  • 23
    • 0030915977 scopus 로고    scopus 로고
    • Accounting for future costs in medical cost-effectiveness analysis
    • [23] Meltzer, D., Accounting for future costs in medical cost-effectiveness analysis. J Health Econ 16 (1997), 33–64.
    • (1997) J Health Econ , vol.16 , pp. 33-64
    • Meltzer, D.1
  • 24
    • 51149098773 scopus 로고    scopus 로고
    • The NICE cost-effectiveness threshold: what it is and what that matters
    • [24] McCabe, C., Claxton, K., Culyer, A.J., The NICE cost-effectiveness threshold: what it is and what that matters. Pharmacoeconomics 26 (2008), 733–744.
    • (2008) Pharmacoeconomics , vol.26 , pp. 733-744
    • McCabe, C.1    Claxton, K.2    Culyer, A.J.3
  • 25
    • 0033914269 scopus 로고    scopus 로고
    • Willingness to pay for a quality-adjusted life year: in search of a standard
    • [25] Hirth, R.A., Chernew, M.E., Miller, E., et al. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making 20 (2000), 332–342.
    • (2000) Med Decis Making , vol.20 , pp. 332-342
    • Hirth, R.A.1    Chernew, M.E.2    Miller, E.3
  • 26
    • 41149171625 scopus 로고    scopus 로고
    • What does the value of modern medicine say about the $50,000 per quality-adjusted life year decision rule?
    • [26] Braithwaite, R.S., Meltzer, D.O., King, J.T., Roberts, M., What does the value of modern medicine say about the $50,000 per quality-adjusted life year decision rule?. Med Care 46 (2008), 349–356.
    • (2008) Med Care , vol.46 , pp. 349-356
    • Braithwaite, R.S.1    Meltzer, D.O.2    King, J.T.3    Roberts, M.4
  • 27
    • 84923209923 scopus 로고    scopus 로고
    • Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold
    • [27] Claxton, K., Martin, S., Soares, M., et al. Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. Health Technol Assess 19 (2015), 1–503.
    • (2015) Health Technol Assess , vol.19 , pp. 1-503
    • Claxton, K.1    Martin, S.2    Soares, M.3
  • 28
    • 84901630147 scopus 로고    scopus 로고
    • ACC/AHA statement on cost/value methodology in clinical practice guidelines and preference measures
    • [28] Anderson, J.L., Heidenreich, P.A., Barnett, P.A., et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and preference measures. J Am Coll Cardiol 63 (2014), 2304–2322.
    • (2014) J Am Coll Cardiol , vol.63 , pp. 2304-2322
    • Anderson, J.L.1    Heidenreich, P.A.2    Barnett, P.A.3
  • 29
    • 84939251874 scopus 로고    scopus 로고
    • American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options
    • [29] Schnipper, L.E., Davidson, N.E., Wollins, D.S., et al. American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options. J Clin Oncol 33 (2015), 2563–2577.
    • (2015) J Clin Oncol , vol.33 , pp. 2563-2577
    • Schnipper, L.E.1    Davidson, N.E.2    Wollins, D.S.3
  • 30
    • 84976398620 scopus 로고    scopus 로고
    • Updating the American Society of Clinical Oncology value framework: revisions and reflections in response to comments received
    • [30] Schnipper, L.E., Davidson, N.E., Wollins, D.S., et al. Updating the American Society of Clinical Oncology value framework: revisions and reflections in response to comments received. J Clin Oncol 34 (2016), 2925–2934.
    • (2016) J Clin Oncol , vol.34 , pp. 2925-2934
    • Schnipper, L.E.1    Davidson, N.E.2    Wollins, D.S.3
  • 32
    • 84952907922 scopus 로고    scopus 로고
    • Measuring the value of prescription drugs
    • [32] Neumann, P.J., Cohen, J.T., Measuring the value of prescription drugs. N Engl J Med 373 (2015), 2595–2597.
    • (2015) N Engl J Med , vol.373 , pp. 2595-2597
    • Neumann, P.J.1    Cohen, J.T.2
  • 33
    • 84959574946 scopus 로고    scopus 로고
    • Multiple criteria decision analysis for health care decision making—emerging good practices: report 2 of the ISPOR MCDA Emerging Good Practices Task Force
    • [33] Marsh, K., IJzerman, M., Thokala, P., et al. Multiple criteria decision analysis for health care decision making—emerging good practices: report 2 of the ISPOR MCDA Emerging Good Practices Task Force. Value Health 19 (2016), 125–137.
    • (2016) Value Health , vol.19 , pp. 125-137
    • Marsh, K.1    IJzerman, M.2    Thokala, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.